Strategic options for global lymphatic filariasis elimination [4]

Trends in Parasitology

Volumn 19, Issue 5, 2003, Pages 200-201

  Sabesan, Shanmugavelu ^a  

^a VECTOR CONTROL RESEARCH CENTRE   (India)

Author keywords

[No Author keywords available]

Indexed keywords

ALBENDAZOLE; DIETHYLCARBAMAZINE;

BLOOD SMEAR; COMMUNITY CARE; DISEASE CARRIER; DISEASE TRANSMISSION; EGYPT; ENDEMIC DISEASE; FILARIASIS; HEALTH PROGRAM; HUMAN; INDIA; INFECTION CONTROL; INFECTION RISK; LETTER; MASS SCREENING; MICROFILARIA; PAPUA NEW GUINEA; PATIENT COMPLIANCE; PREVALENCE; RURAL AREA; TANZANIA; VECTOR CONTROL;

EID: 0038404597     PISSN: 14714922     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1471-4922(03)00068-0     Document Type: Letter

References (7)

1. Reda M., et al. The impact of single-dose diethyl carbamazine treatment of bancroftian filariasis in a low endemicity setting in Egypt. Am. J. Trop. Med. Hyg. 67:2002;196-200.
2. Michael E., et al. Re-assessing the global prevalence and distribution of lymphatic filariasis. Parasitol. 112:1996;409-428.
3. Lymphatic filariasis: the disease and its control. Tech. Rep. Series. 821:1992;45-46.
4. Bockarie M.J., et al. Randomised community-based trial of annual single-dose DEC with or without ivermectin against Wuchereria bancrofti infection in human beings and mosquitoes. Lancet. 351:1998;162-168.
5. Meyrowitsch D.W., et al. Mass diethylcarbamazine chemotherapy for control of bancroftian filariasis: comparative efficacy of standard treatment and two semi-annual single dose treatments. Trans. Roy. Soc. Trop. Med. Hyg. 90:1996;69-73.
6. Balakrishnan N., et al. Efficacy of bi-annual administration of DEC in the control of bancroftian filariasis. J. Com. Dis. 24:1992;87-91.
7. Das P.K., et al. Placebo-controlled community trial of four cycles of single-dose diethylcarbamazine or ivermectin against Wuchereria bancrofti infection and transmission in India. Trans. Roy. Soc. Trop. Med. Hyg. 95:2001;336-341.